Assenagon Asset Management
RVNC

Assenagon Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Assenagon Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-198,846
Closed -$511K – 1504
2024
Q2 		$511K Hold
198,846
– – ﹤0.01% 1243
2024
Q1 		$978K Hold
198,846
– – ﹤0.01% 1060
2023
Q4 		$1.75M Sell
198,846
-215,209
-52% -$1.76M ﹤0.01% 969
2023
Q3 		$4.75M Buy
+414,055
New +$7.96M 0.01% 594
2023
Q2 		– Sell
-194,911
Closed -$6.28M – 1495
2023
Q1 		$6.28M Buy
194,911
+2,552
+1% +$79.6K 0.02% 515
2022
Q4 		$3.55M Sell
192,359
-383,205
-67% -$8.77M 0.01% 623
2022
Q3 		$15.5M Buy
575,564
+444,916
+341% +$9.03M 0.06% 274
2022
Q2 		$1.81M Buy
130,648
+8,389
+7% +$129K 0.01% 868
2022
Q1 		$2.38M Buy
122,259
+3,395
+3% +$51.5K 0.01% 768
2021
Q4 		$1.94M Buy
+118,864
New +$1.98M 0.01% 827
2021
Q3 		– Sell
-141,825
Closed -$4.2M – 1460
2021
Q2 		$4.2M Buy
+141,825
New +$4.09M 0.01% 522
2020
Q2 		– Sell
-16,375
Closed -$242K – 1262
2020
Q1 		$242K Buy
+16,375
New +$339K ﹤0.01% 715

Other funds holding RVNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Assenagon Asset Management's RVNC Position: Q3 2024 in Review

Assenagon Asset Management sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2024, closing a stake of 198,846 shares — an estimated $511K sold.

Assenagon Asset Management first reported a position in RVNC in Q1 2020 and held it in 12 quarters. The position peaked at $15.5M in Q3 2022. 201 funds tracked by Wall St. Rank hold RVNC as of Q3 2024.

  • Assenagon Asset Management reported no remaining Revance Therapeutics, Inc. position as of Q3 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 198,846 Revance Therapeutics, Inc. shares in Q3 2024, an estimated $511K.
  • Assenagon Asset Management first reported a position in Revance Therapeutics, Inc. in Q1 2020 and held it in 12 quarters.
  • Assenagon Asset Management's Revance Therapeutics, Inc. position peaked at $15.5M in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2024.

Based on Assenagon Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.